Schedule at a glance 

[ Pre-conference ] [ Friday, October 9 ] [ Saturday, October 10 ] [ On-demand ] [ Poster list 2020 ]

Pre-conference workshops

September 14

3:00 pm-4:30 pm ET

Intersectional mentoring advances and inclusion practices in family planning

Effective collaborations require that mentees and mentors receive training in psychosocial dimensions of academic and professional life. The importance of implicit bias, trigger recognition, and mitigation strategies in mentoring relationships will be explored. We will highlight the impact of mentors when they demonstrate cultural confidence and engage with novel frameworks.

September 23

3:00 pm-4:30 pm ET

Racial literacy training for family planning providers and learners

We engage participants in actively developing skills borne of concepts from critical race theory, intersectionality, and reproductive justice towards dismantling racial barriers to quality family planning care. We demonstrate the use of narratives and counter narratives to highlight the skills involved in interpreting stories to draw racially conscious insights.

September 29

2:00 pm-3:30 pm ET

What state legislators need from you to champion abortion rights

State legislators are expected to be experts in a host of policy issues. It requires a deeper understanding of legislators for family planning researchers and advocates to collaborate in promoting evidence in the policymaking process. Participants will workshop with state legislators and research translators to create their own tailored plan. 

September 30

6:00 pm - 7:00 pm ET

Leadership opportunities at the Society of Family Planning

Are you interested in developing your career through leadership opportunities in the field of family planning? Join Society of Family Planning leaders for a discussion on current leadership opportunities at the Society, including Board and Special Interest Group leaders.

October 1

2:30 pm-3:30 pm ET

First time attendee coffee chat

We invite first-time attendees of the Annual Meeting to join us for this interactive coffee chat. This session is designed to extend a warm welcome to new attendees by pairing them up with one another and to open the door for sustained social and professional interaction throughout the Annual Meeting.

 [Back to top]

Friday, October 9

11:00 am-11:30 am ET

President’s welcome


11:30 am-12:20 pm ET

“We can make this a story that’s more powerful”: Black women’s perspectives on reproductive health

SisterSong Women of Color Reproductive Justice Collective and Ibis Reproductive Health partnered with organizations in Georgia and North Carolina to capture narratives of the reproductive health experience, concerns, and needs of Black women living in the south. In this session, we present findings from focus group discussions and in-depth interviews.

12:20 pm-12:30 pm ET

Stretch break

Concurrent block I

12:30 pm-1:20 pm ET

Oral abstracts group 1

  • Large-scale trends in contraceptive attitudes over time as expressed on Twitter 

  • Abortion experiences and preferences of transgender, nonbinary, and gender-expansive people in the US: Results from a national quantitative survey 
  • The effect of a narrative intervention on individual-level abortion stigma: A randomized controlled trial
  • The role of complexity and ambiguity in shaping abortion attitudes 

12:30 pm-1:20 pm ET

Listen up! Black and Latinx perspectives on medication abortion

Hosted by the Georgia Medication Abortion Project team at SisterLove and Emory University, this session features Black and Latinx panelists—community members, organization leaders, and researchers—discussing often-marginalized perspectives on medication abortion. This includes  intersectional barriers to services, concerns about exploitation and health risks, and providers' lack of structural and cultural competence.

12:30 pm-1:20 pm ET

Contraception use and experiences at the state level: Findings from the statewide survey of women

Women’s access to contraception varies across states. The statewide survey of women is a new population-based survey that offers an in-depth examination of contraceptive experiences at the state level. This session presents key findings from nine diverse states and discusses the power of state-level data to inform policies and programs.

12:30 pm-1:20 pm ET

Leveraging technology to disseminate reproductive health best practices and build community in low resource settings

Learn how we can disseminate best practices in reproductive health to improve education, training and access using the Project ECHO model of “moving knowledge, not people.” This  low-cost, effective tool can ensure that even the most rural and underserved communities have access to experts in family planning building and expanding local capacity. 

1:20 pm-1:30 pm ET

Stretch break

Concurrent block II

1:30 pm-2:20 pm ET

Oral abstracts group 2

  • Administrators implementing contraceptive policy after the targeted elimination of abortion referrals in Ohio 
  • Gabapentin for pain control during same-day dilation and evacuation: A double-blind randomized controlled trial 

  • “A man takes care of his family”: The influence of masculinity, racial identity, and poverty on young men’s attitudes toward abortion

  •  “Hopefully there’ll be progress”: Illinois providers’ perspectives implementing Medicaid coverage for abortion 

1:30 pm-2:20 pm ET

Considerations for providing developmentally appropriate contraceptive counseling to adolescents

Most contraceptive counseling, as typically implemented, is not tailored to developmental features of adolescence that lead to prioritizing different factors than adult women in contraceptive decision-making. A developmental psychologist, public health interventionist, and adolescent medicine physician will tell you how to incorporate developmentally-appropriate strategies into contraceptive counseling for adolescents.

1:30 pm-2:20 pm ET

Bleeding risk assessment and treatment with dilation and evacuation procedures

This session will review clinical guidelines and contemporary risk assessment tools to evaluate for hemorrhage risk with dilation and evacuation. We plan to review strategies that address clinician and patient needs in freestanding clinics and hospital-based settings. We will also review current literature on tools to decrease bleeding during and after procedures.

1:30 pm-2:20 pm ET

Treating the whole physician: Motivating — and supporting — family physicians to integrate abortion into primary care

Family physicians are well situated to improve abortion access, but many do not provide this care. We will discuss strategies to collaboratively overcome barriers including: improving training, supporting physicians after residency, and motivating physicians. We will break-out into small groups to discuss how to incorporate and optimize these strategies.

2:20 pm-2:30 pm ET

Stretch break


2:30 pm-3:20 pm ET

Awards presentation

Society of Family Planning Mentor Award   

  • Jenny Higgins, PhD, MPH

Society of Family Planning Beacon of Science Award

  • Sonya Borrero, MD, MS

Society of Family Planning Lifetime Achievement Award

  • Maureen Paul, MD, MPH

3:20 pm-3:30 pm ET

Stretch break

3:30 pm-4:20 pm ET

Spotlight on science

  • Out-of-state abortions increased for Texas residents after House Bill 2 

  • Do medication abortion complications increase when restrictive Risk Evaluation and Mitigation Strategy regulations are removed? A population-based study using single-payer linked health administrative data

  • A qualitative exploration of the impact of racism on the reproductive health of US Black women 

  • The levonorgestrel vs. copper intrauterine device for emergency contraception: A non-inferiority randomized controlled trial

4:20 pm-4:25 pm ET

Day one closing remarks

[Back to top]

Saturday, October 10


11:00 am-11:05 am ET

11:05 am-11:55 am ET

Morning welcome

No-test telemedicine abortion during the COVID-19 pandemic: Ethics, experience, and future direction

No-test telemedicine abortion provides a way to improve abortion access as well as decrease the risk of COVID-19 exposure. In this session, we present the evidence, our experience, and the ethics surrounding No-test telemedicine abortion. We discuss the barriers to implementation and the strategies to change our treatment paradigms during and after the pandemic.

11:55 am-12:05 pm ET

Stretch break

Concurrent block III

12:05 pm-12:40 pm ET

Oral abstracts group 3

  • “It creates a hostile environment in your uterus”: Common mischaracterizations of the mechanism of action of emergency contraception in a large online sample 

  • Identifying the optimal time interval between mifepristone and misoprostol administration for management of early pregnancy loss 

  • Exploring access to and attitudes towards abortion and contraception among Black women living in the south 

12:05 pm-12:55 pm ET

The effectiveness of self-managed abortion with accompaniment group support: Results from the SAFE study

Researchers and activists will present results from a co-designed, prospective, non-inferiority study to evaluate the effectiveness of self-managed medication abortion with accompaniment group support. Panelists will discuss leveraging results to shift practice, guidelines, and norms around medication abortion service delivery globally – with direct implications for the US.

12:05 pm-12:55 pm ET

Hormonal contraception and breastfeeding: Implementing best practices for postpartum contraception

Using an interactive format, panel members will share and solicit from the audience best patient-centered practices for discussion regarding postpartum hormonal contraception and breastfeeding based on the current state and gaps in evidence.

12:05 pm-12:55 pm ET

Demystifying open access in SRH research

Much of academic literature is trapped behind paywalls that prevent many - including research partners and research subjects themselves - from accessing it. This session will explore recent advances in increasing access to scholarly literature that are particularly important for policy-relevant findings, and that help make research more visible and discoverable.

Virtual trade show

 12:55 pm-1:25 pm ET Stop by our virtual trade booth to connect with Exhibitors and Sponsors.

Concurrent block IV

1:25 pm-2:15 pm ET

Conducting family planning services research with Federally Qualified Health Center (FQHC) partners

The number of family planning patients served by FQHCs is on the rise, yet few studies have examined family planning service provision in this context. In this session, panelists from across the US will explore the opportunities and challenges in collecting multilevel data in the FQHC setting.

1:25 pm-2:15 pm ET

It’s coming from inside the house: How stigma within pro-choice spaces affects later abortion care seekers

This panel will challenge current abortion advocacy, policy, and care delivery on its failure to include later abortion, identifying a pervasive and unexamined stigma around later abortion that conflicts with our core values. The panelists will begin a conversation about how to address it and dismantle the barriers between patients and their care.

1:25 pm-2:15 pm ET

Moving forward after the implementation of the Trump administration’s Title X regulations

Kaiser Family Foundation, the National Family Planning & Reproductive Health Association, and representatives from Massachusetts, Maryland, and Oregon discuss the impact of the Title X regulations on the Title X network and discuss the future vision and needs for a federal family planning program designed to serve low-income people.

1:25 pm-2:15 pm ET

Daniel R. Mishell, Jr. Outstanding Article Awards

2:15 pm-2:30 pm ET

Stretch break


2:30 pm-3:20 pm ET

Early pregnancy assessment clinics- let’s standardize algorithms, combine with family planning, and overcome disparities

Describe standardization of early pregnancy loss care guidelines in the UK and Canada. Provide an example of integration of early pregnancy care into family planning service delivery with attention to: building referrals, finances, and patient-centered care. Demonstrate how this approach can address disparities in access for abortion and miscarriage patients.

 3:20 pm-3:25 pm ET

Final remarks

4:00 pm ET

Community film night

We invite attendees to close out the conference weekend with a screening of the award-winning film, “Never Rarely Sometimes Always” from the comfort of their own home. Filmmaker and Director Eliza Hittman will be joining us to introduce the film, and answer questions from the audience. Attendees will be able to chat together online during the screening for a truly connected experience.

[Back to top]

On-demand webinars

Available October 7

Building the evidence for direct-to-patient telemedicine for medication abortion

Innovative abortion care models, such as those involving direct-to-patient telemedicine, have emerged to address growing barriers to medication abortion access. In this session, we highlight global and domestic evidence on the efficacy and acceptability of direct-to-patient telemedicine and the role virtual assistants could play to support medication abortion.   

Leveraging an interdisciplinary public health framework to advance understanding of the impacts of abortion restrictions

This panel presents a transdisciplinary public health framework and innovative methods for researchers seeking to evaluate health and socioeconomic impacts of abortion policies. Panelists will examine collaborative approaches for leveraging these resources to inform targeted reform strategies, and explore opportunities for future applications to advance the field of family planning.

Looking back: Lessons and advice from a community-led reproductive justice study on medication abortion

As a follow-up to last year’s much-lauded panel on Restoring Reproductive Justice through Community-Led Research, the SisterLove and Emory University team will look back on the two-year Georgia Medication Abortion Study to offer lessons and advice. Panelists include reproductive justice organization leaders, abortion providers, abortion researchers, and trainees.

It’s a reality: Physician perspectives on our role in the era of self-sourced medication abortion

Self-sourced/managed medication abortion (SMMA) is becoming more common especially in legally restrictive US states. Providers’ opinions on SMMA can vary. This workshop offers data alongside an interactive discussion using examples of SMMA cases from a physician-staffed support hotline to contextualize the issues around SMMA.

Is your research study truly confidential? Digital security for researchers and participants

Do you know what footprints are left behind as study participants share information via the Internet? Learn how a researcher and Digital Defense Fund built security protocols for an SMA study. Workshop scenarios based on tools you use, so you can defend against digital threats to your organization and participants.

Current controversies in care at Catholic health care facilities

This session focuses on the tensions that arise when a secular state-funded health system considers collaboration with a Catholic system. We present stakeholder viewpoints, highlight relevant research, and demonstrate advocacy efforts. Primary domains include 1. disparities in access, 2. outcomes research, 3. patient narratives of discrimination, and 4. ethics.

Experience and acceptability of novel male contraceptive methods

Development of male methods will be a critical breakthrough in reproductive health. NICHD’s pipeline of novel male contraceptive products includes oral and injectable formulations in Phase I trials and a gel formulation undergoing Phase II efficacy evaluation in couples. Clinical updates on effectiveness and acceptability of products will be provided.

Revisiting US sterilization policy: Disparities, potential barriers, and a pathway to reform

People with Medicaid who request sterilization in the US must complete the “consent to sterilization” form. We will review how this policy has become a barrier to care and how it is interpreted differently around the country. We will review advocacy efforts and elicit ideas to reform sterilization policy.   

Clinical strategies to protect and expand access to later abortion in the US

The Later Abortion Initiative will present clinical strategies being employed to protect and expand access to later abortion in the US. These include collaborating with MFM specialists, introducing fetal tissue viewing in later abortion clinics, providing induction abortion, strengthening referral systems in hospital settings, and reducing burden on clients with medically complex conditions.

New and emerging female contraceptives expand options

This session will discuss three newly FDA-approved female contraceptives, and three products in late stage clinical trials, including efficacy and safety information. Speakers will highlight differences from and potential advantages over existing methods. Attendees will subsequently be able to apply information to their own counseling and practices.

Addiction 101: FIlling the gap for the family planning provider

A panel of experts in addiction medicine and family planning will lead an interactive group “bootcamp” (including clinical scenarios) to increase competence in clinical addiction medicine.  

Rooted in RJ: A community-academic research partnership to advance pharmacist-prescribed contraception in rural California

This session will describe how an academic-community research partnership rooted in reproductive justice is conducting an action research project related to implementation of pharmacist-prescribed contraception in rural Central Valley, California, a region that remains underserved by this novel approach to expanding contraceptive access that is now available in 12 states and counting.

Abortion funds and research: Building collaborations that support service delivery and advocacy

This interactive panel discussion will compare lessons learned and differences in approaches to developing collaborations between abortion funds and researchers in three states with highly restrictive abortion policies. The discussion will identify successful strategies for working with abortion fund data and how collaborations can enhance organizational capacity at abortion funds.  

I didn’t know I was pregnant! Understanding the frequency and consequences of later pregnancy recognition

Data dispelling the myth that people usually find out they are pregnant shortly after conception should play a larger role in abortion politics and policymaking. We will mark the other end of the spectrum—people discovering pregnancy at childbirth—and explore how focusing on pregnant people’s knowledge reorients abortion analysis.

Confronting complex emotions: Talking about abortions later in pregnancy

Major moments for abortion in 2020 means the attacks on abortion later in pregnancy will continue. Must this put us on the defensive? With insights from multiple perspectives, panelists will discuss how to embrace the complexity and use it to get ahead attacks on later abortion and take a proactive stance.

Society of Family Planning Clinical Practice Recommendations: 2020 update

This session will summarize Society of Family Planning clinical practice recommendations published in the past year. Panelists will review clinical recommendations regarding: cervical preparation for abortion between 20-24 weeks, contraception for transgender/gender nonconforming individuals, and management of bleeding and thrombotic disorders during abortion.

 Note: times, topics, and speakers may shift as we build the best possible schedule for you. 

[Back to top]

Poster list 2020

Posters will be displayed in a virtual forum

Abortion P1 - P37

  • P1: Miles and days until medication abortion via telemedicine versus clinic in Oregon and Washington. - Kathleen Beardsworth, BS
  • P2: Contraceptive use at last intercourse among reproductive-aged women with disabilities: An analysis of population-based data from 40 US jurisdictions participating in the Behavioral Risk Factor Surveillance System [BRFSS] - Antoinette Nguyen, MD, MPH
  • P3: Efficacy and validity of referrals for abnormal placentation at a tertiary care facility - Amy Stoddard, MD, MSCI
  • P4: Development and validation of a new scale to measure the psychosocial burden of accessing abortion care - M. Antonia Biggs, PhD
  • P5: Public perceptions of physicians who provide abortion care - Meghan Seewald, MA
  • P6: A comparison of arguments strategies, and evidence used by supporters and opponents of “heartbeat” abortion bans across seven Southern states - Subasri Narasimhan, PhD, MPH
  • P7:“All the things that make life harder”: Intersectionality and medication abortion in Georgia - Zainab Jah, MPH
  • P8: Abortion patients’ interest in obtaining medication abortion over-the-counter (OTC) - M. Antonia Biggs, PhD
  • P9: Physician attitudes about abortion and willingness to participate in abortion care and referrals at a Midwestern academic medical center - Nicholas Schmuhl, PhD
  • P11: Crisis pregnancy centers and abortion facilities in the US: A spatial policy analysis - Kavita Vinekar, MD, MPH
  • P12: Transcutaneous electrical nerve stimulation (TENS) for pain control during first-trimester abortion: A single-blinded randomized controlled trial - Klaira Lerma, MPH
  • P13: Experiences of self-managed abortion among transgender, nonbinary, and gender expansive people in the US - Heidi Moseson, PhD, MPH
  • P14: Intimate partner violence is associated with self-managed abortion in Bangladesh - Anvita Dixit, MSc
  • P15: “Georgia has a compelling interest to protect the most vulnerable”: A comparison of arguments and rhetoric used by supporters and opponents of a ‘fetal heartbeat’ ban in Georgia, US - Subasri Narasimhan, PhD, MPH
  • P16: Association between state abortion policies and pregnancy outcomes among individuals seeking abortion recruited using Google Ads: A national cohort study - Ushma Upadhyay, PhD, MPH
  • P17: Examining attitudes toward abortion: Do people’s attitudes change when considering gestational age and fetal development? - Kristen Jozkowski, PhD
  • P18: Improving the travel experiences of later abortion clients: Recommendations from clinics and abortion support organizations - Samantha Ruggiero, MA
  • P19: Attitudes about second-trimester abortion and the impact of restrictive laws among reproductive-aged Texas women - Kari White, PhD, MPH
  • P20: A single-blinded randomized controlled trial evaluating pain and opioid use after cervical dilator placement for second-trimester abortion - Serena M. Liu, MD
  • P21: Pregnancy mementos in induced abortion: A mixed methods analysis - Jonah Fleisher, MD, MPH
  • P22: Using transabdominal ultrasound for first trimester pregnancy dating in an office setting:  A comparison of a wifi and portable machine - Helen Pymar, MD, MPH
  • P23: Medical abortion at or after 13 weeks gestation provided through telemedicine services - Nathalie Kapp, MD, MPH
  • P24: Quality of abortion referrals provided by clinics in Georgia that offer publicly-funded family planning services - Danielle Lambert, PhD, MPH
  • P25: Exploring the association between trust in provider and abortion stigma in the second trimester - Arina Chesnokova, MD, MPH
  • P26: Anesthesia providers perspectives on abortion provision: A qualitative study - Jennifer Reeves, MD, MPH
  • P27: Awareness and support for state funding of crisis pregnancy centers in Georgia: Findings from a statewide representative survey of registered voters - Andrea Swartzendruber, PhD, MPH
  • P28: Breaking down abortion barriers: Reddit users’ empowerment in absence of parental and medical support - Nicole K. Richards, MPH
  • P29: Abortion narratives on Twitter: A mixed methods study - Paris Stowers, MD
  • P30: Patient perspectives about multiple gestations in the setting of abortion seeking - Jessica Klugman, BA
  • P31: A randomized placebo-controlled trial of ondansetron to reduce emesis associated with oral doxycycline - Sarah Betstadt, MD, MPH
  • P32: The silent majority: Physicians’ knowledge of and attitudes toward restrictive abortion policies in a battleground state - Jenny Higgins, PhD, MPH
  • P33: Menstrual regulation: Incidence, methods, and sources of this understudied reproductive practice in three countries - Suzanne Bell, PhD
  • P34: Factors associated with delays obtaining abortion care in Texas - Daniel Grossman, MD
  • P35:Consideration of self-managed abortion among people seeking facility-based care in three haven states - Lauren Ralph, PhD, MPH
  • P36: Anti-abortion protesting: Experience versus access in North Carolina - Whitney Arey, MA
  • P37: Characterizing community-level abortion stigma in the US - Abigail Cutler, MD, MPH

Clinical practice P38 - P47

  • P38: Racial disparities in mental health outcomes among women with early pregnancy loss - Jade Shorter, MD
  • P39: Nurses experience of perinatal loss: A qualitative study on caring for patients undergoing labor induction for fetal demise or fetal anomalies - Blake Zwerling, MD, MSc
  • P40: Increasing access to reproductive health care: Evaluation of a patient transportation assistance program at Planned Parenthood - Elizabeth Talmont, MSN, ANP-BC
  • P41: Impact of product adherence and condom use on rates of urogenital re-infection with Chlamydia trachomatis or Neisseria gonorrhoeae in the AMPREVENCE phase 2b/3 clinical trial - Leandro Mena, MD
  • P42: A new tool for sparking nonjudgmental sexual and reproductive health conversations between adolescents and healthcare providers developed with adolescents using participatory design - Amanda Geppert, CPhil, MPH
  •  P43: Reproductive health service needs and preferences among women utilizing a syringe exchange program in Seattle - Lauren Owens, MD, MPH
  • P44: Phase 3 clinical trial results of a new combined oral contraceptive with estetrol 15mg and drospirenone 3mg - Mitchell Creinin, MD
  • P45: Examining disparities in chlamydia screening among female patients visiting reproductive health centers - Hannah Simons, DrPH
  • P46: Agency in contraceptive decision-making: A newly developed psychometric measure - Corinne Rocca, PhD, MPH
  • P47A tangible decision aid to support patient-centered contraceptive counseling among adolescents and young adults - Crystal Tyler, PhD, MPH

Contraception P48 - P79

  • P48: A randomized trial of the effects of patient race, socioeconomic status, and parity on provider response to request for IUD removal after six months of use - Geffan Pearlson, MS
  • P49: First year expulsion rates and timing in obese and non-obese women after levonorgestrel 52 mg IUS Placement - Gretchen Stuart, MD, MPH
  • P50: A randomized and single-blinded comparative trial of two different-sized copper IUDs to examine bleeding, cramping, and satisfaction/acceptability in a predominantly nulliparous population: Six week results - Kate O’Connell White, MD, MPH
  • P51: The potential environment impact of estetrol, a native estrogen in development for oral contraception - Mitchell Creinin, MD
  • P52: Family planning services for women incarcerated in the US: A scoping review - Joanna Wong, MD, MPH
  • P53: Contraceptive metrics for LARC removal: Findings from a contraceptive intervention - Lavanya Rao, MPH
  • P54: The role of female partners on men’s motivations to have a vasectomy: Findings from a qualitative study in the southern US - Ashley White, PhD
  • P55: Demographic and social factors associated with out-of-pocket expenditures for contraceptive prescriptions in the US during Medicaid expansion - Ashley Brant, DO
  • P56: A pilot study to evaluate the interaction of enzyme-inducing anti-seizure medications with depot medroxyprogesterone acetate - Caryn Dutton, MD, MS
  • P57: Correlates of never-use of long-acting reversible contraception among women who have used contraception in Ohio - Payal Chakraborty, MS
  • P58: Postpartum timing of IUD insertion is associated with risk of IUD expulsion: Results from APEX IUD - Tina R. Raine-Bennett, MD, MPH
  • P59: Racial/Ethnic differences in provision of publicly-funded long-acting contraception to Californian women - Alexandra Calderon, BA
  • P60: Contraindications to hormonal contraception among postpartum women in Texas - Kate Coleman-Minahan, PhD, RN, FNP-BC
  • P61: Postpartum contraception decision-making among mothers of preterm infants requiring intensive care: A qualitative study - Melissa Chen, MD, MPH
  • P62: Risk of uterine perforation and expulsion associated with breastfeeding among postpartum women with an intrauterine device insertion: Results from APEX IUD - Susan D. Reed, MD, MPH, MS
  • P63: Relationship between locus of control and contraceptive use among low-income, minority individuals - Ama Thrasher, MD
  •  P64: Are new LARC users less likely to use condoms than new moderately-effective hormonal method users? An analysis of US women ages 15-44 - Mieke Eeckhaut, PhD
  • P65: Analyzing state-level contraceptive coverage laws with policy surveillance - Elizabeth McCaman, JD, MPH
  • P66: Exploring the experiences and health needs of young womxn living in Ontario, Canada: An action-oriented study dedicated to interpersonal reproductive coercion - Elyse Fortier
  • P67: Non-use of preferred contraceptive method among contracepting women in Ohio - Payal Chakraborty, MS
  • P68: Risk factors for ectopic pregnancy among women of reproductive age - Darios Getahun, MD, PhD, MPH
  • P69: Addressing substance use disorder as a key component of contraceptive counseling for women who use injection drugs - Orli Florsheim, MD
  • P70: LARC Initiation in Oregon School-Based Health Centers (SBHCs): Time trends and disparities in access - Emily Boniface, MPH
  • P71: Characterization of women according to pregnancy status following treatment with VPR during the AMPOWER study - Bassem Maximos, MD, MPH
  • P72: “I really can't take it out now”: Provider and administrator attitudes and experiences with early LARC removal - Jamie Manzer, MPP
  • P73: Employer vs. employee perspectives on religious healthcare denials and insurance networks: A mixed methods study - Lee Hasselbacher, JD
  • P74: Contraceptive care experiences and preferences among Black women in Mississippi: A multi-method qualitative study - Reiley Reed, MPH
  • P75: Rates of procedural complications and patient-centered outcomes after publicly-funded hysteroscopic or laparoscopic sterilization in California - Aileen Gariepy, MD, MPH, MHS
  • P76: Women’s own experiences of how depression influences fertility desires and contraceptive behaviors - Izidora Skracic, MA
  • P77: Examining the association between experiences of reproductive coercion and current contraceptive use - Izidora Skracic, MA
  • P78: Postpartum timing of IUD insertion is associated with risk of uterine perforation: Results from APEX IUD - Susan D. Reed, MD, MPH, MS
  • P79: Effect of delivery room postpartum contraceptive implant insertion on initiation of breastfeeding - Kate Shaw, MD, MS
Other P80 - P81
  • P80: The effect of mifepristone pretreatment on bleeding and pain symptoms during medical management of early pregnancy loss - Andrea Roe, MD, MPH
  • P81: Family planning and the Flint water crisis - Sheila Flaum, DO, MSc

Research practice P82

  • P82: Feasibility of randomization to the copper or levonorgestrel IUD - Jessica Kaplan, MD, MPH

Training/education P83

  • P83Are Wisconsin residents trained in immediate postpartum long-acting reversible contraception? - Kali Rivas, MD

[Back to top]